Clinical Trials Logo

Interaction Drug Food clinical trials

View clinical trials related to Interaction Drug Food.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT05157672 Active, not recruiting - Clinical trials for Interaction Drug Food

Evaluating the Pharmacokinetics and Drug Interaction Potential of the Botanical Dietary Supplement Cinnamon

Start date: December 14, 2021
Phase: Early Phase 1
Study type: Interventional

The purpose of this study is to evaluate a well-characterized, commercially available cinnamon dietary supplement as a precipitant of pharmacokinetic interactions with cytochrome P450 (CYP) 2A6 drug substrates in healthy volunteers. Nicotine gum will be used as the CYP2A6 probe drug (i.e., positive control) and letrozole as a high-impact object drug. Results will be used to inform future research on the potential use of cinnamon as a smoking cessation agent, as well as the clinical impact on pharmacotherapeutic regimens involving letrozole in cancer patients.